Matches in Wikidata for { <http://www.wikidata.org/entity/Q65540609> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q65540609 description "clinical trial" @default.
- Q65540609 description "ensayu clínicu" @default.
- Q65540609 description "klinisch onderzoek" @default.
- Q65540609 description "клінічне випробування" @default.
- Q65540609 name "Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)" @default.
- Q65540609 name "Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome" @default.
- Q65540609 type Item @default.
- Q65540609 label "Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)" @default.
- Q65540609 label "Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome" @default.
- Q65540609 prefLabel "Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)" @default.
- Q65540609 prefLabel "Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome" @default.
- Q65540609 P1050 Q65540609-1E61E085-6517-4E72-9E78-9EE293ACF8B0 @default.
- Q65540609 P1050 Q65540609-7D7426B7-A6FB-42F7-A44B-264DF5E22637 @default.
- Q65540609 P1050 Q65540609-F021D576-88FE-420C-990A-0FA5F14602E8 @default.
- Q65540609 P1132 Q65540609-FAE0F803-57C9-45CB-B98B-36E776E5DC3D @default.
- Q65540609 P1476 Q65540609-29E2C7BB-D07B-4143-8ED9-BB96C313C5E3 @default.
- Q65540609 P17 Q65540609-0221CBCB-0CE7-4780-9186-693851B2030B @default.
- Q65540609 P2899 Q65540609-8E08C9D3-FF70-4BD8-B75D-804F349AF934 @default.
- Q65540609 P3098 Q65540609-9A9FCE87-CDB6-476F-9727-6C4D4B53C9D7 @default.
- Q65540609 P31 Q65540609-D3EB6798-1824-4A80-AA2C-B9C4347AB3BD @default.
- Q65540609 P4135 Q65540609-9623A416-E11F-4D5A-B43B-60E4E24DA071 @default.
- Q65540609 P4844 Q65540609-47446C93-E8D7-4319-8334-8C910A138FA7 @default.
- Q65540609 P580 Q65540609-370B105A-7F66-431F-AE60-05EA15F79A09 @default.
- Q65540609 P582 Q65540609-FBE6A745-0689-473F-9BD3-AAC1AFB85D1C @default.
- Q65540609 P6099 Q65540609-04EAF8AA-2570-48B3-A576-E5E96CB3824C @default.
- Q65540609 P8363 Q65540609-FFB89BCA-DBAE-4C4E-A80F-4C77EEB885E7 @default.
- Q65540609 P1050 Q178436 @default.
- Q65540609 P1050 Q179630 @default.
- Q65540609 P1050 Q838966 @default.
- Q65540609 P1132 "+1821" @default.
- Q65540609 P1476 "A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (c-IBS)" @default.
- Q65540609 P17 Q145 @default.
- Q65540609 P2899 "+18" @default.
- Q65540609 P3098 "NCT00268879" @default.
- Q65540609 P31 Q30612 @default.
- Q65540609 P4135 "+65" @default.
- Q65540609 P4844 Q68414 @default.
- Q65540609 P580 "2005-12-01T00:00:00Z" @default.
- Q65540609 P582 "2008-01-01T00:00:00Z" @default.
- Q65540609 P6099 Q42824827 @default.
- Q65540609 P8363 Q78089383 @default.